Marketplace Dynamics: Autoimmune assesses current and future access and prescribing landscapes for autoimmune drugs, supporting identification of opportunities and risks for brands.
What level of influence do payers and organized providers have on access in the autoimmune drugs market?
How will payer and organized provider management and contracting for branded autoimmune drugs evolve over the next two years, and how should companies prepare for these changes?
How are payers responding to key events in the autoimmune drugs market, such as new approvals and updated clinical data?
Use Marketplace Dynamics: Autoimmune to:
- Closely monitor market evolution
- Identify and monitor access shifts across the payer and organized provider segments
- Assess/predict payers' current and future management of the autoimmune drugs market to facilitate development of effective strategies for inline/pipeline brand(s)
- Identify risks for brands, along with opportunities to improve access
-
Brand Access Influencers and Management Landscape–Autoimmune February
- Road map for improving access for branded autoimmune drugs in 2021
- Analysis of stakeholder approaches to prioritizing and managing the autoimmune drugs market
- Payer use of reimbursement, cost sharing, and utilization management tactics to influence use and restrict access of the autoimmune drug market
- Brand-specific line-of-therapy requirements across autoimmune indications
- Evolving management strategies for brands on the medical benefit, and evolving site-of-care management
- Role of PBMs and specialty pharmacies (SPs) under product selection, distribution, and management
-
Organized Provider Management and Evolving Payment Models–Autoimmune April
- Organized provider use of management tools and tactics to influence drug use and specialist treatment decisions
- Brand-specific line-of-therapy requirements across autoimmune indications
- Prevalence of alternative payment models, innovative financial incentives, and performance metrics, along with associated impacts on drug access
-
Contracting Trends and Insights–Autoimmune June
- Impact and prevalence of contracting in the autoimmune drugs market
- Key contracting terms and success factors driving access gains for branded autoimmune drugs
- Evolution of risk-based contracting agreements for branded autoimmune drugs
-
Outlook on Brand Access in 2024–Autoimmune August
- Evolution of access in the branded autoimmune drugs market
- Predicted management tactics for autoimmune drugs at payers and organized providers by 2024
- Brand access predictions reflecting in-depth future scenarios with high likelihood of occurring